Bihua Chen

Affiliations

  • at Erasca Inc. (ERAS), 2022-12-21
  • Large Shareholder, Director at Biomea Fusion Inc. (BMEA), 2022-06-24
  • Large Shareholder at Moonlake Immunotherapeutics (MLTX), 2022-04-07
  • Other at Vigil Neuroscience Inc. (VIGL), 2022-01-13
  • Other at Ventyx Biosciences Inc. (VTYX), 2021-10-27
  • Director, Other at Pyxis Oncology Inc. (PYXS), 2021-10-15
  • Director, Other at Tyra Biosciences Inc. (TYRA), 2021-09-21
  • Large Shareholder at Immuneering Corp (IMRX), 2021-08-05
  • Other at Icosavax Inc. (ICVX), 2021-08-04
  • Other at Aerovate Therapeutics Inc. (AVTE), 2021-07-07
  • Large Shareholder at Elevation Oncology Inc. (ELEV), 2021-06-24
  • Large Shareholder, Director at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-23
  • Director at Verve Therapeutics Inc. (VERV), 2021-06-23
  • Director at Rain Therapeutics Inc. (RAIN), 2021-04-29
  • Director, Other at Design Therapeutics Inc. (DSGN), 2021-04-01
  • Director, Other at Prometheus Biosciences Inc. (RXDX), 2021-03-18
  • Large Shareholder, Director at Bioatla Inc. (BCAB), 2020-12-22
  • Large Shareholder, Director at Olema Pharmaceuticals Inc. (OLMA), 2020-11-23
  • Large Shareholder, Director at Atea Pharmaceuticals Inc. (AVIR), 2020-11-05
  • Large Shareholder, Director at Akouos Inc. (AKUS), 2020-07-02
  • Large Shareholder, Director at Avidity Biosciences Inc. (RNA), 2020-06-18
  • Large Shareholder, Director at Turning Point Therapeutics Inc. (TPTX), 2019-08-12
  • Large Shareholder, Director at Axonics Modulation Technologies Inc. (AXNX), 2018-11-02
  • Large Shareholder, Director at Constellation Pharmaceuticals Inc (CNST), 2018-07-20
  • Large Shareholder, Director at Kezar Life Sciences Inc. (KZR), 2018-06-27
  • Large Shareholder, Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-31
  • Large Shareholder, Director at Proteostasis Therapeutics Inc. (PTI), 2017-12-18
  • Large Shareholder, Director at Apellis Pharmaceuticals Inc. (APLS), 2017-11-14
  • Large Shareholder, Director at Clearside Biomedical Inc. (CLSD), 2016-06-13
  • Large Shareholder, Director at Cellectar Biosciences Inc. (CLRB), 2014-09-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ERAS $6.50 307,692 10,813,246 2022-12-13 Filing
ERAS $6.50 307,692 10,813,246 2022-12-13 Filing
MLTX $10.00 2,850,000 Large Shareholder 2,850,000 2022-04-05 Filing
ERAS $22.10 200,000 Director 10,505,553 2021-08-10 Filing
ERAS $16.00 950,000 Director 10,505,553 2021-07-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ERAS $18.77 200,000 Director 10,305,553 2021-07-26 Filing